Triclinic Labs

Executive Summary

Triclinic Labs is a San Diego-based CRO specializing in solid-state chemical development and materials characterization for pharmaceutical and chemical clients. Founded in 2009, the company helps optimize physical properties of APIs, derisk development, ensure manufacturing consistency, and strengthen IP portfolios. By providing expert analysis of crystallinity, polymorphism, and stability, Triclinic Labs supports drug development from preclinical through commercial stages. Its services are essential for navigating regulatory requirements and avoiding costly formulation failures. While the company is privately held and does not disclose financials, its niche expertise positions it as a key partner in the pharmaceutical supply chain, particularly as drug developers increasingly focus on bioavailability and manufacturing robustness.

Upcoming Catalysts (preview)

• TBDExpansion of Service Offerings or Capacity50% success
• TBDStrategic Partnership with Major Pharma30% success
• TBDGrowth in Outsourced Solid-State R&D Spending70% success